What is Korro Bio, Inc. Common Stock's Market Cap?

Korro Bio, Inc. Common Stock's Market Cap is $198.7M, based on as-reported figures from SEC (XBRL) filings.

What is Korro Bio, Inc. Common Stock's Price / Sales?

Korro Bio, Inc. Common Stock's Price / Sales is 83.4×, based on as-reported figures from SEC (XBRL) filings.

What is Korro Bio, Inc. Common Stock's Revenue (TTM)?

Korro Bio, Inc. Common Stock's Revenue (TTM) is $2.4M, based on as-reported figures from SEC (XBRL) filings.

What is Korro Bio, Inc. Common Stock's Net Income (TTM)?

Korro Bio, Inc. Common Stock's Net Income (TTM) is -$106.6M, based on as-reported figures from SEC (XBRL) filings.

What is Korro Bio, Inc. Common Stock's EBITDA?

Korro Bio, Inc. Common Stock's EBITDA is -$107.6M, based on as-reported figures from SEC (XBRL) filings.

What is Korro Bio, Inc. Common Stock's Diluted EPS (TTM)?

Korro Bio, Inc. Common Stock's Diluted EPS (TTM) is -7.24, based on as-reported figures from SEC (XBRL) filings.

What is Korro Bio, Inc. Common Stock's EBITDA Margin?

Korro Bio, Inc. Common Stock's EBITDA Margin is -4517.5%, based on as-reported figures from SEC (XBRL) filings.

Korro Bio, Inc. Common Stock (KRRO) Financial Statements

Korro Bio, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00GFMTC47

XNAS · usd

13.49▼ 0.02 (-0.15%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt—

Trading Information

Previous Close13.51

Day's Range11.89 – 13.62

52-Week Range5.20 – 55.89

Volume118.8K

Avg Volume93.3K

Share Statistics

Shares Outstanding

Employees58

ExchangeXNAS

Listed2023-11-06

Share count as of August 5, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Korro Bio, Inc. Common Stock (KRRO)

What is Korro Bio, Inc. Common Stock's Market Cap?: Korro Bio, Inc. Common Stock's Market Cap is $198.7M, based on as-reported figures from SEC (XBRL) filings.
What is Korro Bio, Inc. Common Stock's Price / Sales?: Korro Bio, Inc. Common Stock's Price / Sales is 83.4×, based on as-reported figures from SEC (XBRL) filings.
What is Korro Bio, Inc. Common Stock's Revenue (TTM)?: Korro Bio, Inc. Common Stock's Revenue (TTM) is $2.4M, based on as-reported figures from SEC (XBRL) filings.
What is Korro Bio, Inc. Common Stock's Net Income (TTM)?: Korro Bio, Inc. Common Stock's Net Income (TTM) is -$106.6M, based on as-reported figures from SEC (XBRL) filings.
What is Korro Bio, Inc. Common Stock's EBITDA?: Korro Bio, Inc. Common Stock's EBITDA is -$107.6M, based on as-reported figures from SEC (XBRL) filings.
What is Korro Bio, Inc. Common Stock's Diluted EPS (TTM)?: Korro Bio, Inc. Common Stock's Diluted EPS (TTM) is -7.24, based on as-reported figures from SEC (XBRL) filings.
What is Korro Bio, Inc. Common Stock's EBITDA Margin?: Korro Bio, Inc. Common Stock's EBITDA Margin is -4517.5%, based on as-reported figures from SEC (XBRL) filings.